Novel Albicidin Derivatives, Their Use and Synthesis

Simple SummaryContent extracted from patent full text and abstract with AI.

This patent describes a new class of albicidin derivatives—compounds that are structurally related to a natural product known for its antibiotic properties. Albicidin is naturally produced by certain bacteria and acts as a DNA-gyrase inhibitor, making it a potent antibiotic against both gram-positive and gram-negative bacteria. The invention covers the chemical structure, synthesis methods, and pharmaceutical uses of these novel derivatives. These compounds show significant antibacterial activity and are intended for use as treatments for a broad spectrum of bacterial infections, including drug-resistant strains.

Use CasesContent extracted from patent full text and abstract with AI.

• Development of new antibiotic drugs to treat bacterial infections, including those caused by gram-positive and gram-negative bacteria.
• Treating infections from clinically important bacteria such as Escherichia coli, Salmonella, Klebsiella, Pseudomonas, Staphylococcus, and Streptococcus.
• Therapies for multidrug-resistant or hard-to-treat bacterial strains.
• Formulations for use in hospital and community-acquired infection management.
• Potential use in veterinary medicine for similar bacterial pathogens.
• Pharmaceutical compositions for oral, intravenous, topical, or inhalation delivery.

BenefitsContent extracted from patent full text and abstract with AI.

• Effective against both gram-positive and gram-negative bacteria, including some that are resistant to current antibiotics.
• Demonstrates strong antibacterial activity at low concentrations (low MIC values).
• Multiple structural variants allow for optimization of efficacy, safety, and pharmacokinetics.
• Can be formulated for improved water solubility (e.g., with cyclodextrins), enhancing drug delivery options.
• Potential for use as a next-generation antibiotic to address the growing issue of antibiotic resistance.
• Diverse administration routes (oral, injectable, topical, etc.) increase versatility in clinical settings.
• Potential for customization and combination therapies based on different bacterial threats.

Technical Classifications (CPCs)

Inventors & Applicants

Patent Abstract

The present invention relates to a chemical compound according to general formula (1), which has an antibiotic activity.